APA

Takeuchi S., Zhao S., Kuge Y., Zhao Y., Nishijima K., Hatano T., Shimizu Y., Kinoshita I., Tamaki N. & Dosaka-Akita H. (20111024). 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts. : Oncology reports.

Chicago

Takeuchi Satoshi, Zhao Songji, Kuge Yuji, Zhao Yan, Nishijima Ken-Ichi, Hatano Toshiyuki, Shimizu Yasushi, Kinoshita Ichiro, Tamaki Nagara and Dosaka-Akita Hirotoshi. 20111024. 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts. : Oncology reports.

Harvard

Takeuchi S., Zhao S., Kuge Y., Zhao Y., Nishijima K., Hatano T., Shimizu Y., Kinoshita I., Tamaki N. and Dosaka-Akita H. (20111024). 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts. : Oncology reports.

MLA

Takeuchi Satoshi, Zhao Songji, Kuge Yuji, Zhao Yan, Nishijima Ken-Ichi, Hatano Toshiyuki, Shimizu Yasushi, Kinoshita Ichiro, Tamaki Nagara and Dosaka-Akita Hirotoshi. 18F-fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts. : Oncology reports. 20111024.